Abstract
Objective: To investigate community tobacco control leaders' attitudes toward harm reduction approaches to tobacco use, in order to assess benefits and risks associated with these strategies.
Design: Cross sectional design involving qualitative outcomes from nine structured focus groups.
Subjects: 47 community tobacco control leaders in Minnesota working in the areas of public policy, clinical treatment of nicotine dependence and youth development participated.
Outcome measures: Participants discussed definitions of harm reduction; benefits and risks of harm reduction methods; and how funds for tobacco control research and programmes should be allocated.
Results: Results indicated inconsistency about the definition of harm reduction: most groups included a broad range of strategies that extended beyond those typically referenced in the scientific literature. Many participants stated that harm reduction might be beneficial, particularly for smokers who could not or would not quit. However, most also expressed concern about a number of risks, including delivering a mixed message about tobacco, inadvertently benefiting the tobacco industry, and causing unanticipated negative health effects. Participants were inclined to suggest public policy measures (for example, smoking bans, increased taxes) as means for reducing harm.
Conclusions: Results indicate that even among tobacco control leaders there is a need for common terminology to describe harm reduction approaches and that public policy approaches to harm reduction are considered more dependable than strategies that involve pharmaceutical treatment or rely on the tobacco industry, such as product modification.
Full Text
The Full Text of this article is available as a PDF (71.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Colletti G., Supnick J. A., Rizzo A. A. Long-term follow-up (3-4 years) of treatment for smoking reduction. Addict Behav. 1982;7(4):429–433. doi: 10.1016/0306-4603(82)90014-4. [DOI] [PubMed] [Google Scholar]
- Etter Jean-François, Laszlo Evelyne, Zellweger Jean-Pierre, Perrot Charles, Perneger Thomas V. Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial. J Clin Psychopharmacol. 2002 Oct;22(5):487–495. doi: 10.1097/00004714-200210000-00008. [DOI] [PubMed] [Google Scholar]
- Fagerström K. O., Tejding R., Westin A., Lunell E. Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker? Tob Control. 1997 Winter;6(4):311–316. doi: 10.1136/tc.6.4.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hatsukami Dorothy K., Slade John, Benowitz Neal L., Giovino Gary A., Gritz Ellen R., Leischow Scott, Warner Kenneth E. Reducing tobacco harm: research challenges and issues. Nicotine Tob Res. 2002;4 (Suppl 2):S89–101. doi: 10.1080/1462220021000032852. [DOI] [PubMed] [Google Scholar]
- Hughes J. R. Reduced smoking: an introduction and review of the evidence. Addiction. 2000 Jan;95 (Suppl 1):S3–S7. doi: 10.1080/09652140032008. [DOI] [PubMed] [Google Scholar]
- Hurt R. D., Croghan G. A., Wolter T. D., Croghan I. T., Offord K. P., Williams G. M., Djordjevic M. V., Richie J. P., Jr, Jeffrey A. M. Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine Tob Res. 2000 Nov;2(4):327–336. doi: 10.1080/713688154. [DOI] [PubMed] [Google Scholar]
- Kozlowski L. T., Strasser A. A., Giovino G. A., Erickson P. A., Terza J. V. Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction. Tob Control. 2001 Sep;10(3):201–203. doi: 10.1136/tc.10.3.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Riggs R. L., Hughes J. R., Pillitteri J. L. Two behavioral treatments for smoking reduction: a pilot study. Nicotine Tob Res. 2001 Feb;3(1):71–76. doi: 10.1080/14622200020032114. [DOI] [PubMed] [Google Scholar]
- Shiffman Saul, Gitchell Joe G., Warner Kenneth E., Slade John, Henningfield Jack E., Pinney John M. Tobacco harm reduction: conceptual structure and nomenclature for analysis and research. Nicotine Tob Res. 2002;4 (Suppl 2):S113–S129. doi: 10.1080/1462220021000032717. [DOI] [PubMed] [Google Scholar]